With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

Q1 2025 Management View CEO Eric Green highlighted that the company exceeded expectations for revenues and adjusted EPS in Q1 ...

Currently in the process of expanding its offices, Tegan Innovations is a showcase for Waterford’s highly skilled workforce ...

As the pharmaceutical industry continues to evolve with increasing regulatory expectations, this success story provides ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Technology cooperation with global pharmaceutical companies not only stimulates growth in manufacturing, R&amp,D spaces of the country, but also positively impacts patients’ health with ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

West Pharmaceutical Servs WST is preparing to release its quarterly earnings on Thursday, 2025-04-24. Here's a brief overview ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) announced in Q1 CY2025, but sales were flat year on year ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter ...

Waterford is striking the balance between being a place that holds over 1,000 years of history and being a place of ...